Display options
Share it on

Open Forum Infect Dis. 2014 Jun 19;1(1):ofu010. doi: 10.1093/ofid/ofu010. eCollection 2014 Mar.

Antiretroviral Therapy (ART) Use, Human Immunodeficiency Virus (HIV)-1 RNA Suppression, and Medical Causes of Hospitalization Among HIV-Infected Intravenous Drug Users in the Late ART Era.

Open forum infectious diseases

Gabriel Vallecillo, Sergio Mojal, Marta Torrens, Roberto Muga

Affiliations

  1. Departments of Internal Medicine and Drug Addiction Unit of Psychiatry.
  2. Department of Statistics and Operations Research, Parc de Recerca Biomédica de Barcelona, Barcelona, Spain.
  3. Drug Addiction Unit of Psychiatry, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.

PMID: 25734084 PMCID: PMC4324207 DOI: 10.1093/ofid/ofu010

Abstract

BACKGROUND: Antiretroviral therapy (ART) has reduced the rates and changed the causes of hospital admission. However, human immunodeficiency virus-positive intravenous drug users (HIV-IDU) continue to have increased hospitalizations and discharge diagnosis are less defined in the late ART era. Our aim was to examine ART use, HIV-1 RNA suppression, and hospital discharge diagnoses among HIV-IDU admitted to an urban hospital.

METHODS: A retrospective analysis was made of HIV-IDU admitted for medical causes for the first time (2006-2010). Surgical, obstetric, or mental (except HIV-associated neurocognitive disorder) diagnoses were excluded. Clinical characteristics, number of admissions, and primary discharge diagnoses were determined for each patient.

RESULTS: Three hundred and seventy-five admissions were recorded among 197 hospitalized HIV-IDU. Lifetime prevalence of ART use was 83.2% (164 of 197) and the rate of HIV-1 RNA <50 copies/mL was 38.1% (75 of 197). Primary discharge diagnosis groups were as follows: bacterial infections (59.2%), chronic end-organ damage (16.8%), complications derived from injected drug use (16.8%), malignancies (9.1%), and opportunistic infections (6.6%). Chronic end-organ damage was diagnosed more frequently in patients with HIV-1 RNA <50 copies/mL (36% vs 4.9%; P < .000), and complications derived from injected drug use (23.8% vs 5.3%; P < .0008) and acquired immune deficiency syndrome (AIDS) opportunistic infections (19.8% vs 1.3% P < .019) were usually diagnosed in patients with HIV-1 RNA detectable viral load.

CONCLUSIONS: Human immunodeficiency virus-positive intravenous drug users are admitted to hospitals mainly for non-AIDS-related illnesses; however, sustained HIV-1 RNA viral load suppression is poor and determines hospital discharge diagnoses. Providers need to be aware of the management of HIV-related comorbidities and reinforce strategies to improve ART retention in this population.

Keywords: HIV-infected drug users; antiretroviral therapy; hospitalization

References

  1. AIDS Behav. 2013 Jan;17(1):68-73 - PubMed
  2. Addiction. 2008 Nov;103(11):1828-36 - PubMed
  3. MMWR Morb Mortal Wkly Rep. 2012 Mar 2;61(8):133-8 - PubMed
  4. AIDS. 2007 Jul 11;21(11):1473-7 - PubMed
  5. AIDS. 2008 Jul 11;22(11):1345-54 - PubMed
  6. AIDS Behav. 2013 Jan;17(1):168-73 - PubMed
  7. AIDS Care. 2011 Aug;23(8):980-7 - PubMed
  8. J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):331-7 - PubMed
  9. Drug Alcohol Depend. 2012 Jul 1;124(1-2):108-12 - PubMed
  10. Curr HIV Res. 2010 Dec;8(8):649-58 - PubMed
  11. Clin Infect Dis. 2007 Sep 15;45(6):770-8 - PubMed
  12. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S22-32 - PubMed
  13. J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):360-6 - PubMed
  14. J Viral Hepat. 2009 May;16(5):352-8 - PubMed
  15. Med Care. 2005 Sep;43(9 Suppl):III40-52 - PubMed
  16. Addiction. 2004 Mar;99(3):361-8 - PubMed
  17. J Acquir Immune Defic Syndr. 2010 Mar;53(3):397-404 - PubMed
  18. J Health Care Poor Underserved. 2007 Aug;18(3):675-86 - PubMed
  19. HIV Med. 2006 Oct;7(7):457-66 - PubMed
  20. CMAJ. 2001 Aug 21;165(4):415-20 - PubMed
  21. HIV Med. 2009 Aug;10(7):407-16 - PubMed
  22. Med Care. 2005 Sep;43(9 Suppl):III3-14 - PubMed
  23. Clin Infect Dis. 2009 Nov 1;49(9):1433-40 - PubMed
  24. Clin Infect Dis. 2013 Aug;57 Suppl 2:S62-9 - PubMed
  25. AIDS. 2005 May 20;19(8):837-9 - PubMed
  26. Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S318-23 - PubMed
  27. J Acquir Immune Defic Syndr. 2010 Jul;54(3):248-57 - PubMed
  28. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):609-16 - PubMed
  29. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):173-82 - PubMed
  30. HIV Med. 2004 Nov;5(6):437-47 - PubMed
  31. Clin Infect Dis. 2008 Oct 15;47(8):1102-4 - PubMed
  32. Clin Chest Med. 2013 Jun;34(2):205-16 - PubMed
  33. AIDS Behav. 2008 Mar;12(2):284-93 - PubMed
  34. AIDS Patient Care STDS. 2007 Aug;21(8):564-74 - PubMed
  35. Clin Infect Dis. 2006 Jun 1;42(11):1628-35 - PubMed
  36. Drug Alcohol Depend. 2007 Jul 10;89(2-3):306-9 - PubMed
  37. BMC Public Health. 2010 Jun 09;10:327 - PubMed

Publication Types